e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Diagnostic issues in obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adiponectin and epicardial fat in patients with obstructive sleep apnoea
M. Sova (Olomouc, Czech Republic), S. Genzor (Olomouc, Czech Republic), E. Sovova (Olomouc, Czech Republic), A. Ghazal Asswad (Olomouc, Czech Republic)
Source:
International Congress 2019 – Diagnostic issues in obstructive sleep apnoea
Session:
Diagnostic issues in obstructive sleep apnoea
Session type:
Thematic Poster
Number:
811
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Sova (Olomouc, Czech Republic), S. Genzor (Olomouc, Czech Republic), E. Sovova (Olomouc, Czech Republic), A. Ghazal Asswad (Olomouc, Czech Republic). Adiponectin and epicardial fat in patients with obstructive sleep apnoea. 811
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Leptin in obstructive sleep apnea
Source: Eur Respir J 2001; 18: Suppl. 33, 333s
Year: 2001
Visceral fat in non-to-moderate and severe obstructive sleep apnoea
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 332s
Year: 2004
Insulin resistance in obstructive sleep apnea patients
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Can leptin be used to treat obstructive sleep apnoea?
Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside
Year: 2019
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 447s
Year: 2004
Cortisol metabolism in obstructive sleep apnea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 215s
Year: 2002
Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 445s
Year: 2004
The inflammation and insulin resistance in obstructive sleep apnea
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Serum leptin levels in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
Serum fibrinogen in patients with obstructive sleep apnea
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020
Roles of periostin in patients with severe obstructive sleep apnea
Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers
Year: 2017
Cardiac echo indices in patients with obstructive sleep apnea and COPD
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009
Markers of liver dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment
Source: Eur Respir J 2003; 22: 251-257
Year: 2003
Influence of body weight on plasma NT-proBNP in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea
Year: 2007
Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Metabolic disturbances in patients with obstructive sleep apnoea syndrome
Source: Eur Respir Rev 2007; 16: 196-202
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept